Skin Changes in Breast Cancer Patients on Hormone Therapy or Chemotherapy
Part of Cancer, Skin clinical trials.
This study measures how your skin changes physically and mechanically during breast cancer treatment. It may help doctors better manage side effects like skin dryness or tightness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 70 years old.
- You are currently receiving tamoxifen, an aromatase inhibitor, or paclitaxel as part of your treatment after surgery (with or without radiation).
- If you are on hormone therapy, you must have stopped any chemotherapy at least 30 days ago.
- You did not have chronic skin conditions (like psoriasis, lupus, or severe eczema) before you started this treatment.
- You understand the study and can make your own decisions about joining.
- You are willing and able to complete all the required tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how cancer treatments (anti–PD-1/PD-L1/CTLA-4 medicines or CDK inhibitors) affect your skin and overall quality of life. You may fill out questionnaires during the study to help researchers understand changes over time.
This study looks at how proton therapy affects the skin in people being treated for early-stage breast cancer. It aims to understand skin reactions better so doctors can reduce side effects.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
This study looks at how changes in the skin’s normal bacteria (microbiome) relate to getting redness, irritation, or rash after breast radiation. It may help doctors predict who is more likely to have skin side effects after reconstruction and radiation.
This trial tests whether a corticosteroid cream can prevent or reduce hand-foot skin reactions caused by liposomal doxorubicin (a type of chemotherapy) in breast cancer patients. If you are starting this chemo and are concerned about skin side effects, this study may offer a way to manage them.
This study asks a group of expert healthcare professionals to agree on the best ways to care for the skin of breast cancer patients. It uses a step-by-step online survey process to reach consensus.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.